— Know what they know.
Not Investment Advice
Also trades as: 0HMZ.L (LSE) · $vol 0M

WRB NYSE

W. R. Berkley Corporation
1W: -1.1% 1M: +7.0% 3M: -4.2% YTD: +5.6% 1Y: -0.8% 3Y: +85.3% 5Y: +138.2%
$72.38
-1.41 (-1.91%)
 
Weekly Expected Move ±3.3%
$69 $71 $73 $76 $78
NYSE · Financial Services · Insurance - Property & Casualty · Tech Score Buy · Power 72 · $26.9B mcap · 244M float · 1.00% daily turnover · Short 37% of daily vol
Credit Risk of going bust: not rated, financial company (lending is its business) Bonds: none of note held by US funds details ▾
Not rated: lending and leverage are a financial company's business, which the model misreads.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

WEAK EDGE
45.2 / 100
NoneWeakNarrowWide
Primary source: Efficient Scale  ·  ROIC: 19.3%  ·  5Y Avg: 14.9%
Cost Advantage
42
Intangibles
51
Switching Cost
24
Network Effect
40
Scale ★
80
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. WRB shows a Weak competitive edge (45.2/100) — limited structural advantages that may face competitive pressure. The primary source of advantage is Efficient Scale. ROIC of 19.3% confirms the company is generating returns well above its cost of capital — a hallmark of durable competitive advantages.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$73
Low
$76
Avg Target
$79
High
Based on 2 analysts since Oct 19, 2026 earnings
Analyst Recommendations
Strong Buy: 0Buy: 7Hold: 17Sell: 6Strong Sell: 0
Rating Summary
ConsensusHold
Avg Target$71.40
Analysts5
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-10-26 UBS — $77 $79 +2 +6.6% $74.11
2026-10-20 Mizuho Securities Yaron Kinar $70 $73 +3 -1.5% $74.11
2026-10-12 Wells Fargo — $58 $65 +7 -9.6% $71.91
2026-10-07 Mizuho Securities — $74 $70 -4 +0.5% $69.65
2026-10-06 Morgan Stanley Bob Huang $73 $70 -3 -0.2% $70.14
2026-07-27 UBS — $68 $77 +9 +1.8% $75.61
2026-07-21 Mizuho Securities — $72 $74 +2 +1.8% $72.71
2026-07-21 Oppenheimer — Initiated $70 — -3.7% $72.71
2026-07-15 Atlantic Equities — Initiated $74 — +4.7% $70.67
2026-07-10 Evercore ISI — $69 $68 -1 -5.6% $72.03
2026-07-09 Cantor Fitzgerald — $71 $74 +3 +3.8% $71.28
2026-07-09 Mizuho Securities Yaron Kinar $69 $72 +3 +1.0% $71.28
2026-06-12 Barclays Alex Scott $64 $62 -2 -8.2% $67.54
2026-06-08 Wells Fargo — $68 $58 -10 -15.4% $68.57
2026-04-27 UBS — $71 $68 -3 +2.0% $66.64
2026-04-23 BMO Capital — $64 $68 +4 +0.7% $67.50
2026-04-09 Cantor Fitzgerald Ryan Tunis $75 $71 -4 +5.6% $67.21
2026-02-02 Cantor Fitzgerald Ryan Tunis $76 $75 -1 +10.5% $67.87
2026-02-02 UBS — $87 $71 -16 +3.5% $68.58
2026-01-28 Morgan Stanley — $75 $73 -2 +8.2% $67.50
2026-01-27 Truist Financial — $84 $80 -4 +19.2% $67.09
2026-01-14 Cantor Fitzgerald — $78 $76 -2 +9.2% $69.60
2026-01-14 Mizuho Securities Yaron Kinar $67 $69 +2 +1.5% $68.00
2026-01-13 Wells Fargo — $66 $68 +2 -1.0% $68.71
2026-01-08 Barclays Alex Scott $73 $64 -9 -7.6% $69.29
2026-01-07 Goldman Sachs — $69 $73 +4 +6.6% $68.49
2026-01-07 Evercore ISI — $60 $69 +9 -1.4% $69.99
2025-12-16 Morgan Stanley — $80 $75 -5 +8.5% $69.10
2025-12-15 Mizuho Securities — Initiated $67 — -3.0% $69.10
2025-11-17 Morgan Stanley — $68 $80 +12 +3.2% $77.51
2025-10-27 Cantor Fitzgerald — $82 $78 -4 +3.9% $75.11
2025-10-22 BMO Capital — $89 $64 -25 -14.7% $75.00
2025-10-21 Truist Financial — $68 $84 +16 +14.3% $73.48
2025-10-21 Wells Fargo Elyse Greenspan $70 $66 -4 -10.2% $73.48
2025-10-21 Jefferies Andrew Andersen $57 $75 +18 +2.1% $73.48
2025-10-08 UBS — $69 $87 +18 +11.9% $77.77
2025-10-08 Barclays — $56 $73 +17 -6.1% $77.77
2025-08-12 Cantor Fitzgerald Ryan Tunis Initiated $82 — +17.1% $70.01
2025-04-22 Wells Fargo Elyse Greenspan $59 $70 +11 -1.2% $70.85
2024-11-25 Goldman Sachs Robert Cox $61 $69 +8 +10.8% $62.27
2024-10-23 CFRA Catherine Seifert Initiated $67 — +13.3% $59.13
2024-10-22 UBS Brian Meredith $92 $69 -23 +17.9% $58.53
2024-10-22 Bank of America Securities Joshua Shanker Initiated $76 — +24.5% $61.03
2024-10-22 RBC Capital Scott Heleniak $88 $63 -25 +3.2% $61.03
2024-10-22 Goldman Sachs Alex Scott $83 $61 -22 -0.0% $61.03
2024-10-22 Evercore ISI David Motemaden Initiated $60 — -1.7% $61.03
2024-10-17 Truist Financial Mark Hughes Initiated $68 — +14.7% $59.28
2024-10-09 Jefferies Yaron Kinar Initiated $57 — -0.8% $57.47
2024-09-04 Barclays Alex Scott Initiated $56 — -7.6% $60.58
2024-07-23 Wells Fargo Elyse Greenspan Initiated $59 — +13.9% $51.82

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

B+
Oct 27, 2026
DCF
5
ROE
5
ROA
5
D/E
1
P/E
2
P/B
1
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. WRB receives an overall rating of B+. Strongest factors: DCF (5/5), ROE (5/5), ROA (5/5). Areas of concern: D/E (1/5), P/E (2/5), P/B (1/5).
Rating Change History
DateFromTo
2026-10-27 B- B+
2026-10-20 A- B-
2026-10-16 A A-
2026-10-12 A- A
2026-05-04 B+ A-
2026-05-01 B- B+
2026-04-22 C B-
2026-04-21 A- C
2026-02-17 B- A-
2026-01-27 C B-

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 71 Grade A+
Profitability
58
Balance Sheet
64
Earnings Quality
93
Growth
56
Value
69
Momentum
82
Safety
—
Cash Flow
73
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. WRB scores highest in Earnings Quality (93/100) and lowest in Growth (56/100). An overall grade of A+ places WRB among the highest-quality companies in its peer group.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman-I Score
1.25
Distress Zone
Piotroski F-Score
7/9
✓ ✓ ✗ ✓ ✓ ✗ ✓ ✓ ✓
Beneish M-Score
-1.70
Possible Manipulator
Ohlson O-Score
—
—
Credit Rating
BB+
Score: 49.6/100
Trend: Deteriorating
Earnings Quality
100/100
OCF/NI: 1.82x
Accruals: -3.4%
The Altman-I Score is adapted for insurance companies, emphasizing return on equity, tangible net worth, and cash reserves alongside the standard equity and earnings components. WRB scores 1.25, placing it in the Distress Zone (safe > 3.0, distress < 1.5). Historically, companies in this range face elevated bankruptcy risk. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. WRB scores 7/9, signaling strong financial health across all three dimensions. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. WRB's score of -1.70 exceeds the −1.78 red flag threshold — this does not confirm manipulation but indicates the earnings profile resembles past manipulators statistically. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. WRB receives an estimated rating of BB+ (score: 49.6/100), with a deteriorating trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). WRB's score of 100/100 is high — cash flows strongly support reported earnings.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
15.24x
PEG
-14.63x
P/S
1.49x
P/B
2.86x
P/FCF
8.15x
P/OCF
7.80x
EV/EBITDA
10.90x
EV/Revenue
1.47x
EV/EBIT
10.73x
EV/FCF
8.15x
Earnings Yield
7.05%
FCF Yield
12.27%
Shareholder Yield
4.91%
Graham Number
$51.91
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 15.2x earnings, WRB trades at a reasonable valuation. An earnings yield of 7.0% exceeds typical risk-free rates, suggesting equities are being compensated for risk. Graham's intrinsic value formula yields $51.91 per share, 39% below the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
0.797
NI / EBT
×
Interest Burden
0.949
EBT / EBIT
×
EBIT Margin
0.137
EBIT / Rev
×
Asset Turnover
0.402
Rev / Assets
×
Equity Multiplier
4.551
Assets / Equity
=
ROE
19.0%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. WRB's ROE of 19.0% is driven by financial leverage (equity multiplier: 4.55x). Note: high leverage means ROE is amplified by debt rather than operational performance.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
12.37%
Fair P/E
33.23x
Intrinsic Value
$158.20
Price/Value
0.43x
Margin of Safety
57.31%
Premium
-57.31%
Assessment
Neutral
Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with WRB's realized 12.4% 3-year EPS CAGR, capped at 15% — demonstrated performance rather than forecasts, held to a rate companies have historically sustained. WRB trades at a -57% premium to its adjusted intrinsic value of $158.20, suggesting the market is pricing in future growth beyond what historical earnings support. The adjusted fair P/E of 33.2x compares to the current market P/E of 15.2x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$72.37
Median 1Y
$79.91
5th Pctile
$52.28
95th Pctile
$122.13
Ann. Volatility
27.7%
Analyst Target
$71.40
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
William R. Berkley
Chairman of the Board and Chief Executive Officer
$1,000,000 $— $11,159,578
W. Robert Berkley,
Jr. President and Chief Operating Officer
$850,000 $— $4,197,741
Eugene G. Ballard
Senior Vice President— Chief Financial Officer
$605,000 $— $1,451,109
Ira S. Lederman
Senior Vice President— General Counsel and Secretary
$605,000 $— $1,450,749
James G. Shiel
Senior Vice President— Investments
$605,000 $— $1,445,742

CEO Pay Ratio

Insufficient data for pay ratio.

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
8,804
+2.3% YoY
Revenue / Employee
$1,670,324
Rev: $14,705,530,000
Profit / Employee
$202,113
NI: $1,779,402,000
SGA / Employee
—
Avg labor cost proxy

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
ROE 15.8% 20.8% 20.3% 19.9% 20.6% 15.7% 18.8% 20.6% 19.5% 20.8% 21.1% 20.6% 22.2% 20.7% 20.6% 20.9% 19.7% 20.1% 19.8% 19.0% 18.97%
ROA 3.4% 4.5% 4.2% 4.0% 4.2% 3.3% 3.7% 3.9% 3.9% 4.2% 4.2% 4.1% 4.5% 4.4% 4.3% 4.5% 4.2% 4.4% 4.4% 4.2% 4.17%
ROIC -12.5% -15.8% -15.1% -14.1% -14.7% -11.4% -12.5% -12.6% -12.4% -13.4% -12.9% -12.2% -13.4% -12.8% -12.6% -12.2% -11.3% -11.8% -11.8% 19.3% 19.29%
ROCE 4.5% 5.8% 5.4% 5.2% 5.5% 4.3% 4.9% 5.1% 5.1% 5.5% 5.4% 5.4% 5.9% 5.7% 5.6% 14.6% 13.7% 14.2% 14.1% 5.4% 5.39%
Gross Margin 22.9% 30.7% 15.9% 15.6% 24.6% 20.3% 22.8% 20.7% 24.9% 24.0% 21.1% 21.1% 25.2% 22.1% 18.4% 18.2% 20.6% 47.5% 71.3% 1.0% 1.00%
Operating Margin 13.8% 25.1% 8.9% 10.5% 15.9% 13.0% 15.3% 13.9% 15.6% 17.6% 14.7% 14.0% 19.9% 15.2% 14.2% 17.7% 16.3% 16.7% 8.4% 15.4% 15.36%
Net Margin 11.4% 20.3% 7.1% 8.4% 12.7% 10.2% 11.9% 11.0% 12.3% 13.6% 11.2% 10.8% 15.7% 11.8% 10.9% 13.6% 12.1% 14.0% 6.6% 11.9% 11.93%
EBITDA Margin 16.3% 27.2% 10.6% 12.0% 17.3% 14.4% 16.2% 14.8% 15.8% 16.1% 13.7% 14.5% 20.4% 15.8% 14.7% 17.8% 16.2% 17.1% 8.6% 16.2% 16.21%
FCF Margin 22.4% 22.4% 23.5% 22.2% 22.5% 22.3% 22.9% 24.9% 23.7% 25.1% 25.7% 26.3% 26.2% 25.9% 24.0% 22.7% 23.3% 22.7% 19.4% 18.0% 18.04%
OCF Margin 23.1% 23.0% 23.9% 22.7% 23.0% 22.8% 23.4% 25.4% 24.1% 25.8% 26.5% 27.0% 27.0% 26.4% 24.5% 23.2% 24.5% 23.7% 20.1% 18.9% 18.86%
ROE 3Y Avg snapshot only 19.03%
ROE 5Y Avg snapshot only 19.45%
ROA 3Y Avg snapshot only 4.12%
ROIC 3Y Avg snapshot only 14.05%
ROIC Economic snapshot only 19.29%
Cash ROA snapshot only 7.42%
Cash ROIC snapshot only 34.44%
CROIC snapshot only 32.95%
NOPAT Margin snapshot only 10.56%
Pretax Margin snapshot only 13.00%
R&D / Revenue snapshot only 0.00%
SGA / Revenue snapshot only 0.00%
SBC / Revenue snapshot only 0.00%
Valuation
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
P/E Ratio 13.40 12.05 13.03 12.66 13.30 14.58 11.83 11.68 12.96 14.62 12.97 13.78 12.86 15.84 16.23 15.65 15.54 13.79 14.31 14.19 15.238
P/S Ratio 1.45 1.63 1.66 1.53 1.65 1.42 1.28 1.34 1.47 1.79 1.56 1.65 1.66 1.97 2.00 2.04 1.88 1.74 1.53 1.47 1.495
P/B Ratio 2.06 2.43 2.65 2.58 2.72 2.28 2.17 2.31 2.40 2.87 2.58 2.58 2.69 3.08 3.07 3.04 2.85 2.66 2.70 2.69 2.859
P/FCF 6.47 7.29 7.04 6.87 7.30 6.37 5.61 5.38 6.22 7.14 6.08 6.27 6.32 7.60 8.32 8.96 8.06 7.68 7.89 8.15 8.149
P/OCF 6.27 7.09 6.93 6.73 7.15 6.23 5.49 5.27 6.11 6.93 5.89 6.09 6.14 7.46 8.17 8.78 7.68 7.35 7.62 7.80 7.796
EV/EBITDA -0.77 0.49 1.03 0.47 1.17 -0.45 -1.18 -0.98 -0.40 1.59 0.14 0.19 0.49 2.20 2.30 1.70 0.73 -0.08 0.26 10.90 10.901
EV/Revenue -0.13 0.10 0.19 0.08 0.20 -0.06 -0.18 -0.15 -0.06 0.25 0.02 0.03 0.08 0.36 0.38 0.29 0.12 -0.01 0.04 1.47 1.470
EV/EBIT -0.84 0.52 1.09 0.49 1.20 -0.46 -1.20 -0.99 -0.40 1.50 0.13 0.17 0.46 2.11 2.25 1.67 0.72 -0.08 0.26 10.73 10.734
EV/FCF -0.57 0.42 0.79 0.36 0.88 -0.28 -0.78 -0.62 -0.26 1.00 0.08 0.11 0.31 1.38 1.56 1.28 0.50 -0.06 0.19 8.15 8.149
Earnings Yield 7.5% 8.3% 7.7% 7.9% 7.5% 6.9% 8.5% 8.6% 7.7% 6.8% 7.7% 7.3% 7.8% 6.3% 6.2% 6.4% 6.4% 7.2% 7.0% 7.0% 7.05%
FCF Yield 15.5% 13.7% 14.2% 14.6% 13.7% 15.7% 17.8% 18.6% 16.1% 14.0% 16.4% 15.9% 15.8% 13.2% 12.0% 11.2% 12.4% 13.0% 12.7% 12.3% 12.27%
Price/Tangible Book snapshot only 2.685
EV/OCF snapshot only 7.796
EV/Gross Profit snapshot only 2.375
Acquirers Multiple snapshot only 11.142
Shareholder Yield snapshot only 4.91%
Graham Number snapshot only $51.91
Leverage & Solvency
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
Current Ratio 15.50 — — — — — — — — — — — — — — 1.40 1.39 1.38 1.37 — —
Quick Ratio 15.50 — — — — — — — — — — — — — — 1.40 1.39 1.38 1.37 — —
Debt/Equity 0.49 0.41 0.44 0.45 0.42 0.41 0.41 0.41 0.38 0.36 0.37 0.34 0.34 0.32 0.31 0.29 0.29 0.29 0.28 0.00 0.000
Net Debt/Equity -2.24 -2.29 -2.35 -2.45 -2.39 -2.38 -2.47 -2.57 -2.50 -2.47 -2.54 -2.53 -2.56 -2.52 -2.50 -2.61 -2.67 -2.68 -2.64 0.00 0.000
Debt/Assets 0.10 0.09 0.09 0.09 0.08 0.08 0.08 0.08 0.08 0.07 0.07 0.07 0.07 0.07 0.07 0.06 0.06 0.06 0.06 0.00 0.000
Debt/EBITDA 2.09 1.43 1.51 1.57 1.49 1.85 1.62 1.52 1.53 1.44 1.46 1.43 1.28 1.26 1.21 1.13 1.20 1.16 1.14 0.00 0.000
Net Debt/EBITDA -9.56 -7.91 -8.16 -8.59 -8.47 -10.77 -9.70 -9.50 -10.02 -9.78 -10.21 -10.77 -9.68 -9.95 -9.91 -10.15 -10.93 -10.67 -10.82 0.00 0.000
Interest Coverage 9.72 12.82 12.80 12.75 14.19 11.71 13.55 14.58 14.76 16.33 16.59 17.04 18.84 18.56 18.82 20.18 18.95 19.57 19.99 19.44 19.437
Equity Multiplier 4.83 4.70 5.02 5.21 5.02 4.94 5.13 5.22 4.99 4.86 5.01 4.79 4.83 4.64 4.59 4.46 4.54 4.55 4.48 4.64 4.640
Debt Service Coverage snapshot only 19.140
Defensive Interval snapshot only 0.0 days
Efficiency & Turnover
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
Asset Turnover 0.31 0.33 0.33 0.33 0.34 0.33 0.34 0.35 0.34 0.35 0.35 0.35 0.35 0.35 0.35 0.35 0.35 0.35 0.41 0.40 0.402
Inventory Turnover — — — — — — — — — — — — — — — — — — — — —
Receivables Turnover 1.79 1.93 1.83 1.87 1.92 1.83 1.81 1.86 1.85 1.85 1.84 1.85 1.97 1.98 1.99 2.03 2.12 2.08 2.50 5.05 5.049
Payables Turnover 14.94 15.67 14.94 14.81 15.94 16.90 16.13 15.42 16.36 15.72 14.93 15.07 16.18 16.23 16.26 17.11 18.36 17.20 15.61 21.88 21.879
DSO 204 189 199 195 190 200 201 196 198 197 198 197 185 184 183 180 172 175 146 72 72.3 days
DIO 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.0 days
DPO 24 23 24 25 23 22 23 24 22 23 24 24 23 22 22 21 20 21 23 17 16.7 days
Cash Conversion Cycle 179 166 175 170 167 178 179 173 175 174 174 173 163 162 161 158 152 154 123 56 55.6 days
Capital Intensity snapshot only 2.541
Growth (YoY)
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
Revenue 16.7% 20.9% 18.5% 16.8% 18.1% 9.1% 11.5% 11.2% 8.7% 12.2% 10.3% 10.5% 12.3% 11.4% 11.4% 11.1% 7.8% 6.6% 26.0% 22.7% 22.68%
Net Income 92.7% 81.0% 42.5% 24.3% 35.1% -21.6% -4.8% 5.6% 0.0% 41.0% 22.5% 15.5% 27.1% 13.2% 13.9% 20.8% 1.3% 8.4% 9.5% -2.3% -2.26%
EPS 94.2% 81.7% 43.0% 24.5% 34.9% -21.1% -2.6% 8.8% 2.9% 44.6% 24.3% 17.0% 28.9% 14.9% 14.9% 21.3% 1.8% 9.8% 11.9% -0.0% -0.04%
FCF 34.1% 31.3% 47.0% 22.7% 18.8% 8.5% 8.4% 24.4% 14.3% 26.3% 23.9% 16.7% 24.2% 15.1% 4.2% -3.9% -4.0% -6.6% 1.9% -2.6% -2.60%
EBITDA 57.5% 52.6% 25.7% 11.9% 22.2% -22.9% -6.7% 3.7% -2.4% 28.5% 10.6% 5.9% 19.3% 14.6% 20.8% 26.9% 6.8% 8.3% 6.3% -3.7% -3.69%
Op. Income 82.0% 70.7% 36.6% 20.2% 34.0% -20.7% -2.7% 8.5% 2.0% 43.2% 24.1% 17.7% 29.1% 14.2% 14.1% 20.5% 3.1% 8.2% 8.9% -3.4% -3.42%
OCF Growth snapshot only -0.21%
Asset Growth snapshot only 4.49%
Equity Growth snapshot only 0.45%
Debt Growth snapshot only -1.00%
Shares Change snapshot only -2.22%
Dividend Growth snapshot only 24.75%
Growth (CAGR)
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
Revenue 3Y 7.1% 9.7% 9.9% 10.9% 12.2% 12.8% 14.8% 15.4% 14.5% 14.0% 13.3% 12.8% 13.0% 10.9% 11.1% 10.9% 9.6% 10.0% 15.7% 14.6% 14.63%
Revenue 5Y 4.0% 5.8% 6.2% 6.8% 8.7% 8.6% 9.3% 10.2% 9.6% 10.1% 10.3% 10.9% 11.5% 12.4% 13.2% 13.6% 12.7% 11.9% 15.4% 14.4% 14.36%
EPS 3Y 18.3% 29.8% 25.7% 24.6% 28.2% 31.0% 54.7% 61.3% 39.2% 27.5% 20.1% 16.6% 21.4% 9.4% 11.6% 15.6% 10.5% 22.2% 16.9% 12.4% 12.37%
EPS 5Y 11.8% 18.8% 17.8% 19.6% 21.1% 13.7% 15.0% 17.0% 18.1% 20.1% 19.2% 19.7% 22.8% 30.1% 39.5% 42.9% 28.8% 21.2% 17.4% 14.0% 13.97%
Net Income 3Y 16.9% 28.3% 24.2% 23.0% 26.5% 29.7% 53.1% 59.3% 37.6% 26.0% 18.4% 14.9% 19.8% 7.8% 9.9% 13.8% 8.8% 20.1% 15.2% 10.9% 10.89%
Net Income 5Y 11.2% 18.0% 17.0% 18.8% 20.3% 12.9% 13.7% 15.6% 16.6% 18.5% 17.4% 17.8% 20.8% 28.4% 38.0% 41.3% 27.4% 19.7% 15.7% 12.4% 12.36%
EBITDA 3Y 12.3% 21.0% 17.3% 17.1% 19.4% 20.4% 34.4% 34.6% 23.4% 14.8% 9.1% 7.1% 12.5% 4.4% 7.6% 11.7% 7.6% 16.9% 12.4% 9.0% 9.00%
EBITDA 5Y 6.8% 12.0% 10.5% 11.6% 13.0% 7.4% 8.9% 10.9% 11.1% 11.9% 10.7% 12.0% 14.7% 20.8% 26.5% 26.8% 19.1% 13.4% 10.8% 8.5% 8.49%
Gross Profit 3Y 13.6% 20.2% 16.8% 15.6% 18.5% 20.8% 33.0% 35.8% 26.0% 20.1% 15.0% 13.5% 15.6% 8.2% 9.1% 10.0% 5.8% 21.7% 49.1% 61.5% 61.53%
Gross Profit 5Y 10.6% 17.9% 17.4% 18.9% 19.9% 15.9% 17.4% 19.8% 14.3% 15.3% 14.2% 14.9% 16.1% 20.7% 24.5% 23.9% 16.7% 18.4% 33.4% 40.2% 40.23%
Op. Income 3Y 16.5% 27.4% 23.3% 22.5% 26.3% 30.2% 52.7% 56.5% 35.5% 24.7% 18.2% 15.3% 20.9% 9.0% 11.3% 15.5% 10.7% 20.9% 15.5% 11.1% 11.06%
Op. Income 5Y 7.4% 13.7% 12.6% 14.7% 17.3% 11.3% 13.0% 15.3% 16.7% 18.6% 17.8% 18.6% 21.6% 29.3% 38.2% 40.3% 27.1% 19.1% 15.5% 12.3% 12.31%
FCF 3Y 54.8% 49.8% 41.1% 31.2% 32.4% 29.4% 28.7% 28.6% 22.1% 21.7% 25.5% 21.2% 19.1% 16.4% 11.9% 11.8% 10.9% 10.7% 9.6% 3.0% 3.01%
FCF 5Y 21.6% 25.6% 31.6% 33.8% 33.4% 37.9% 37.1% 45.5% 38.2% 35.8% 30.5% 26.8% 27.0% 25.8% 22.4% 19.0% 16.8% 14.1% 16.0% 10.8% 10.79%
OCF 3Y 52.1% 48.4% 40.3% 31.4% 31.0% 27.7% 27.2% 26.8% 21.9% 22.1% 25.2% 21.2% 19.0% 16.1% 11.9% 11.8% 11.9% 11.6% 10.0% 3.9% 3.86%
OCF 5Y 20.8% 24.6% 27.5% 30.5% 29.3% 32.7% 35.0% 41.6% 36.4% 35.1% 30.4% 27.2% 26.3% 24.7% 21.5% 18.0% 17.4% 14.7% 15.9% 11.1% 11.09%
Assets 3Y 1.9% 0.9% 0.2% 0.8% 8.3% 9.5% 8.9% 8.6% 9.2% 8.3% 8.7% 8.6% 8.1% 8.6% 9.3% 9.7% 9.2% 8.9% 9.0% 8.1% 8.15%
Assets 5Y 2.4% 2.3% 2.2% 2.1% 2.6% 2.7% 3.3% 3.5% 4.1% 3.8% 3.7% 4.5% 8.8% 9.6% 9.3% 9.2% 9.0% 8.3% 8.6% 7.7% 7.68%
Equity 3Y 7.0% 6.0% 2.9% 1.6% 3.6% 8.1% 5.9% 4.9% 5.7% 6.7% 5.7% 8.2% 8.1% 9.1% 12.6% 15.6% 12.9% 11.9% 14.0% 12.5% 12.49%
Book Value 3Y 8.3% 7.3% 4.1% 2.9% 4.9% 9.2% 7.0% 6.2% 7.0% 7.9% 7.2% 9.8% 9.6% 10.8% 14.3% 17.4% 14.6% 13.9% 15.7% 14.0% 13.98%
Dividend 3Y 63.7% 63.1% 79.5% 30.7% -11.8% 2.2% 4.8% -13.3% 30.2% 1.2% 9.3% 39.7% 3.4% 14.7% 7.9% -5.2% 11.3% 11.6% -5.8% 8.3% 8.27%
Growth Quality
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
Revenue Stability 0.57 0.60 0.63 0.67 0.81 0.86 0.86 0.90 0.90 0.94 0.96 0.98 0.98 1.00 1.00 1.00 0.99 1.00 0.94 0.96 0.955
Earnings Stability 0.38 0.50 0.43 0.48 0.68 0.60 0.60 0.64 0.79 0.76 0.79 0.80 0.90 0.86 0.89 0.91 0.91 0.83 0.94 0.94 0.945
Margin Stability 0.88 0.79 0.76 0.75 0.81 0.79 0.77 0.77 0.87 0.88 0.93 0.93 0.92 0.84 0.81 0.81 0.88 0.88 0.61 0.41 0.406
Rev. Growth Consistency 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Earn. Growth Consistency 0.50 1.00 1.00 1.00 1.00 0.00 0.00 1.00 1.00 0.50 0.50 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 0.00 0.000
FCF Positive Streak 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Earnings Persistence 0.50 0.50 0.83 0.90 0.86 0.91 0.98 0.98 1.00 0.84 0.91 0.94 0.89 0.95 0.94 0.92 0.99 0.97 0.96 0.99 0.991
Earnings Smoothness 0.37 0.42 0.65 0.78 0.70 0.76 0.95 0.95 1.00 0.66 0.80 0.86 0.76 0.88 0.87 0.81 0.99 0.92 0.91 0.98 0.977
ROE Trend 0.06 0.10 0.10 0.10 0.09 -0.00 0.01 0.02 0.01 0.02 0.01 -0.01 0.01 0.02 -0.00 0.00 -0.01 -0.00 -0.01 -0.00 -0.002
Gross Margin Trend 0.04 0.06 0.05 0.04 0.03 -0.03 -0.01 0.00 0.01 0.01 0.01 0.01 0.01 0.01 -0.00 -0.01 -0.03 0.03 0.23 0.40 0.400
FCF Margin Trend 0.06 0.05 0.06 0.03 0.02 0.01 0.02 0.03 0.01 0.03 0.03 0.03 0.03 0.02 -0.00 -0.03 -0.02 -0.03 -0.05 -0.06 -0.064
Sustainable Growth Rate 10.3% 15.5% 14.8% 14.0% 17.1% 10.3% 12.9% 17.0% 12.4% 15.7% 14.3% 12.4% 15.4% 14.3% 13.6% 15.3% 11.9% 12.6% 14.9% 12.6% 12.65%
Internal Growth Rate 2.2% 3.4% 3.2% 2.9% 3.6% 2.2% 2.6% 3.4% 2.5% 3.3% 2.9% 2.6% 3.3% 3.1% 2.9% 3.4% 2.6% 2.8% 3.4% 2.9% 2.86%
Cash Flow Quality
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
OCF/Net Income 2.14 1.70 1.88 1.88 1.86 2.34 2.15 2.22 2.12 2.11 2.20 2.26 2.09 2.12 1.99 1.78 2.02 1.88 1.88 1.82 1.820
FCF/OCF 0.97 0.97 0.98 0.98 0.98 0.98 0.98 0.98 0.98 0.97 0.97 0.97 0.97 0.98 0.98 0.98 0.95 0.96 0.97 0.96 0.957
FCF/Net Income snapshot only 1.741
OCF/EBITDA snapshot only 1.398
CapEx/Revenue 0.7% 0.6% 0.4% 0.5% 0.5% 0.5% 0.5% 0.5% 0.4% 0.8% 0.8% 0.8% 0.8% 0.5% 0.4% 0.5% 1.2% 1.0% 0.7% 0.8% 0.82%
Accruals Ratio -0.04 -0.03 -0.04 -0.04 -0.04 -0.04 -0.04 -0.05 -0.04 -0.05 -0.05 -0.05 -0.05 -0.05 -0.04 -0.04 -0.04 -0.04 -0.04 -0.03 -0.034
Sloan Accruals snapshot only -0.233
Cash Flow Adequacy snapshot only 4.417
Earnings Quality Score snapshot only 1.000
Dividends & Buybacks
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
Dividend Yield 2.6% 2.1% 2.1% 2.3% 1.3% 2.3% 2.7% 1.5% 2.8% 1.7% 2.5% 2.9% 2.4% 1.9% 2.1% 1.7% 2.5% 2.7% 1.7% 2.3% 2.60%
Dividend/Share $0.85 $0.85 $0.85 $0.91 $0.56 $0.89 $0.97 $0.59 $1.23 $0.91 $1.24 $1.56 $1.33 $1.34 $1.50 $1.27 $1.75 $1.78 $1.22 $1.59 $1.88
Payout Ratio 34.8% 25.8% 27.0% 29.5% 17.0% 34.2% 31.6% 17.6% 36.3% 24.3% 32.4% 39.7% 30.3% 30.8% 34.1% 26.7% 39.4% 37.5% 24.9% 33.3% 33.32%
FCF Payout Ratio 16.8% 15.6% 14.6% 16.0% 9.3% 14.9% 15.0% 8.1% 17.4% 11.8% 15.2% 18.1% 14.9% 14.8% 17.5% 15.3% 20.4% 20.9% 13.7% 19.1% 19.14%
Total Payout Ratio 46.8% 32.5% 34.0% 30.0% 23.8% 55.3% 73.0% 55.5% 75.2% 50.5% 53.9% 61.4% 47.6% 51.2% 41.4% 34.1% 54.5% 65.4% 57.8% 69.7% 69.70%
Div. Increase Streak 0 0 0 0 0 1 1 0 0 0 1 0 1 0 1 0 1 1 0 0 0
Chowder Number 3.25 3.21 4.60 1.17 -0.33 0.06 0.14 -0.36 1.16 0.02 0.28 1.64 0.08 0.46 0.22 -0.17 0.34 0.34 -0.18 0.24 0.243
Buyback Yield 0.9% 0.6% 0.5% 0.0% 0.5% 1.5% 3.5% 3.2% 3.0% 1.8% 1.7% 1.6% 1.3% 1.3% 0.5% 0.5% 1.0% 2.0% 2.3% 2.6% 2.56%
Net Buyback Yield 0.9% 0.6% 0.5% 0.0% 0.5% 1.4% 3.5% 3.2% 3.0% 1.8% 1.7% 1.6% 1.3% 1.3% 0.5% 0.5% 1.0% 2.0% 2.3% 2.6% 2.56%
Total Shareholder Return 3.5% 2.7% 2.6% 2.4% 1.8% 3.8% 6.2% 4.8% 5.8% 3.5% 4.2% 4.5% 3.7% 3.2% 2.6% 2.2% 3.5% 4.7% 4.0% 4.9% 4.91%
DuPont Factors
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
Tax Burden (NI/EBT) 0.80 0.80 0.81 0.81 0.80 0.80 0.79 0.79 0.79 0.78 0.78 0.77 0.78 0.78 0.78 0.78 0.78 0.80 0.80 0.80 0.797
Interest Burden (EBT/EBIT) 0.90 0.92 0.92 0.92 0.93 0.91 0.93 0.93 0.93 0.94 0.94 0.94 0.95 0.95 0.95 0.95 0.95 0.95 0.95 0.95 0.949
EBIT Margin 0.15 0.18 0.17 0.16 0.17 0.13 0.15 0.16 0.15 0.17 0.16 0.16 0.18 0.17 0.17 0.17 0.16 0.17 0.14 0.14 0.137
Asset Turnover 0.31 0.33 0.33 0.33 0.34 0.33 0.34 0.35 0.34 0.35 0.35 0.35 0.35 0.35 0.35 0.35 0.35 0.35 0.41 0.40 0.402
Equity Multiplier 4.68 4.67 4.81 4.97 4.92 4.82 5.07 5.22 5.00 4.90 5.06 4.98 4.91 4.74 4.78 4.61 4.68 4.59 4.53 4.55 4.551
Per Share
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
EPS (Diluted TTM) $2.45 $3.30 $3.16 $3.08 $3.30 $2.61 $3.08 $3.36 $3.40 $3.77 $3.83 $3.93 $4.38 $4.33 $4.40 $4.76 $4.46 $4.75 $4.92 $4.76 $4.76
Book Value/Share $15.92 $16.39 $15.54 $15.13 $16.13 $16.69 $16.81 $16.98 $18.34 $19.19 $19.25 $20.97 $20.94 $22.29 $23.21 $24.48 $24.30 $24.67 $26.04 $25.15 $142.81
Tangible Book/Share $15.31 $15.99 $15.13 $14.72 $15.69 $16.25 $16.39 $16.56 $17.91 $18.76 $18.80 $20.51 $20.48 $21.83 $22.75 $21.45 $21.34 $21.64 $22.99 $25.15 $25.15
Revenue/Share $22.63 $24.39 $24.88 $25.58 $26.69 $26.79 $28.39 $29.31 $29.87 $30.82 $31.76 $32.83 $34.02 $34.84 $35.68 $36.62 $36.84 $37.61 $45.96 $45.94 $46.25
FCF/Share $5.07 $5.46 $5.85 $5.68 $6.01 $5.96 $6.50 $7.29 $7.08 $7.72 $8.17 $8.62 $8.91 $9.03 $8.58 $8.32 $8.59 $8.54 $8.93 $8.29 $8.94
OCF/Share $5.23 $5.61 $5.95 $5.80 $6.14 $6.10 $6.63 $7.43 $7.21 $7.96 $8.43 $8.88 $9.18 $9.19 $8.74 $8.49 $9.02 $8.93 $9.24 $8.66 $9.25
Cash/Share $43.49 $44.28 $43.33 $43.77 $45.38 $46.47 $48.40 $50.66 $52.86 $54.42 $56.03 $60.21 $60.69 $63.27 $65.06 $70.94 $72.10 $73.26 $76.01 $0.00 $0.00
EBITDA/Share $3.73 $4.74 $4.48 $4.31 $4.56 $3.68 $4.27 $4.60 $4.58 $4.85 $4.80 $4.94 $5.54 $5.64 $5.85 $6.29 $5.94 $6.19 $6.35 $6.20 $6.20
Debt/Share $7.82 $6.79 $6.77 $6.78 $6.78 $6.82 $6.92 $6.97 $6.99 $6.99 $7.03 $7.06 $7.09 $7.11 $7.10 $7.10 $7.11 $7.20 $7.25 $0.00 $0.00
Net Debt/Share $-35.67 $-37.49 $-36.56 $-37.00 $-38.60 $-39.66 $-41.48 $-43.70 $-45.87 $-47.42 $-49.00 $-53.15 $-53.60 $-56.16 $-57.96 $-63.85 $-64.99 $-66.07 $-68.76 $0.00 $0.00
Academic Models
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
Altman-I Score — — — — — — — — — — — — — — — — — — — — 1.254
Piotroski F-Score 6 8 7 7 7 6 7 8 7 8 7 8 8 7 7 7 6 8 8 7 7
Beneish M-Score -2.56 -2.63 -2.40 -2.39 -2.40 -2.16 -2.60 -2.61 -2.55 -2.72 -2.63 -2.65 -2.67 -2.59 -2.53 -2.87 -2.83 -3.25 -3.03 -1.70 -1.699
Net-Net WC snapshot only $25.15
EVA snapshot only $914295648.39
Credit
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
Credit Rating snapshot only BB+
Credit Score 79.59 85.45 86.51 87.71 85.86 86.51 86.19 85.83 85.14 87.68 86.39 86.50 87.54 87.89 87.29 89.23 87.50 87.18 87.54 49.56 49.560
Credit Grade snapshot only 11
Credit Trend snapshot only -39.668
Implied Spread (bps) snapshot only 400.000
Industry Credit Rank snapshot only 0
Sector Credit Rank snapshot only 38

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms